Skip to content

Clinical trials

Phase 3 Diabetes Mellitus trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 3 Country / region: Italy Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20021
20034
20042
20054
20066
20076
20084
20096
20105
20113
20124
20134
20144
20166
20177
20203
20211
20221
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Terminated6
Unknown status4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S38
AstraZeneca7
Eli Lilly and Company3
Mario Negri Institute for Pharmacological Research3
Takeda3
Bayer2
Consorzio Mario Negri Sud2
Kodiak Sciences Inc2
Pfizer2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus79
Diabetes Mellitus, Type 245
Diabetes Mellitus, Type 115
Glucose Metabolism Disorders5
Metabolic Diseases4
Coronary Artery Disease3
Endocrine System Diseases3
Hypertension3
Macular Edema3
Obesity3

Trials

Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.